CareDx Health (CDNA): Net earnings per share (EPS TTM)

CareDx Inc (CDNA) - corporate logo

Profit dependence on AlloSure and AlloMap genomic test sales may create volatility, as evidenced by CareDx, Inc (CDNA) TTM net income per share, where the latest parameter is 2.41. However, the digital health monitoring environment makes CareDx, Inc (CDNA) an indispensable partner for clinics. A stable moat and the integration of molecular diagnostics into medical standards securely protect the business's position.

CDNA caredx.com Net earnings per share for the last four quarters (07/04/2022 - 11/15/2026)

Summary analytical data breakdowns for CareDx, Inc (CDNA)

- current quotes and average value forecast:
- stock exchange capitalization data:
General company analysis:CareDx Health (CDNA)
Manufactured products of CareDx Health

CareDx, Inc (CDNA) diversification across organ transplantation sectors and the implementation of digital software minimize profit dependence on local changes in medical protocols. By analyzing the rolling net income per share trend, an investor sees the final annual financial result divided by the total number of securities, which allows for an objective assessment of the real return on each ownership stake and capital stability.

Main competitors

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|MRVI - Earnings per share for the last twelve months|FLGT: Earnings per share for the last twelve months|LAB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc (CTKB)|Net earnings per share for the last 12 months OSUR|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months